These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6962540)

  • 1. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
    Lee SP
    Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).
    Wieriks J; Hespe W; Jaitly KD; Koekkoek PH; Lavy U
    Scand J Gastroenterol Suppl; 1982; 80():11-6. PubMed ID: 6962539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)).
    Li W; Jin L; Zhu N; Hou X; Deng F; Sun H
    J Am Chem Soc; 2003 Oct; 125(41):12408-9. PubMed ID: 14531674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.
    Slomiany BL; Nishikawa H; Bilski J; Slomiany A
    Am J Gastroenterol; 1990 Apr; 85(4):390-3. PubMed ID: 2109526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).
    Baron JH; Barr J; Batten J; Sidebotham R; Spencer J
    Gut; 1986 May; 27(5):486-90. PubMed ID: 3084345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-ulcer activity of colloidal bismuth subcitrate in Shay-rats.
    Lavy UI; Koekkoek PH; Jaitly KD
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):291-8. PubMed ID: 1015926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scanning electron microscopic morphological and semi-quantitative evaluation of rat stomach treated with colloidal bismuth subcitrate and alcohol.
    Winters C; Hinsull SM; Gregory Z
    Scanning Microsc; 1991 Jun; 5(2):541-7; discussion 547-8. PubMed ID: 1947936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal defences and gastroduodenal disease.
    Tasman-Jones C; Maher C; Thomsen L; Lee SP; Vanderwee M
    Digestion; 1987; 37 Suppl 2():1-7. PubMed ID: 3622945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.
    Muñoz DJ; Tasman-Jones C; Pybus J
    Gut; 1992 May; 33(5):592-6. PubMed ID: 1377152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
    Balint GA
    Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of bismuth glycyrrhizate on experimental gastric ulcers and its mechanisms].
    Ji XL; Jiang YX; Ren BB; Liu K; Liu G
    Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(14):1429-32. PubMed ID: 17966358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
    Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
    Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical response to colloidal bismuth subcitrate: dose-time effect.
    Türkez H; Geyikoğlu F; Keleş MS
    Biol Trace Elem Res; 2005; 105(1-3):151-8. PubMed ID: 16034160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol).
    Hollanders D; Morrissey SM; Mehta J
    Br J Clin Pract; 1983 Mar; 37(3):112-4. PubMed ID: 6882629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.